EXACT SCIENCES CORP - Common Stock (EXAS)

CUSIP: 30063P105

Q1 2023 13F Holders as of 31 Mar 2023

Holder snapshot 7 signals
Share change
+919,367
Put/Call ratio
122%
SEC-reported price per share
$67.81
Number of holders
575
Value change
+$84,761,923
Number of buys
283
Open additional details 1 more signal available
Number of sells
226
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
193,646,400

Security key

30063P105

Report period

Q1 2023

Institutions

575

Top holders

10

Ownership snapshot

Top reported holders of EXAS - EXACT SCIENCES CORP - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Disclosed value leader
Comparable rows
0/0
Latest evidence
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
575
Shares
164,425,577
Rows available
575
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q1 2023 Across Filers

Q1 2023 holders
575
Q1 2023 holders
575
Holder diff
0
Investor Q1 2023 Shares Q1 2023 Shares Share Diff Share Chg % Q1 2023 value Q1 2023 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .